Simulation and prediction of in vivo drug metabolism in human populations from in vitro data (Q28286115)

Nature Reviews Drug Discovery

Europe PubMed Central

title

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data (English)

0 references

main subject

Simcyp Simulator

0 references

author name string

Amin Rostami-Hodjegan

series ordinal

1

0 references

Geoffrey T Tucker

series ordinal

2

0 references

language of work or name

English

0 references

publication date

February 2007

0 references

published in

0 references

volume

6

0 references

page(s)

140-8

0 references

issue

2

0 references

cites work

The planning of a clinical trials workshop

1 reference

Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices

21 January 2018

1 reference

Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data

21 January 2018

1 reference

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

Severe hypoxemia and liver disease

21 January 2018

1 reference

Sense and nonsense in the prediction of drug-drug interactions

21 January 2018

1 reference

Utility of metabolic stability screening: comparison of in vitro and in vivo clearance

31 March 2020

1 reference

An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates

31 March 2020

1 reference

'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions

31 March 2020

1 reference

Simulation of clinical trials

31 March 2020

1 reference

Computer simulation of a clinical trial as an aid to teaching the concept of statistical significance

31 March 2020

1 reference

Clinical trial experience by simulation: a workshop report

31 March 2020

1 reference

Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies--moving the "goalposts" or changing the "game".

31 March 2020

1 reference

Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment.

31 March 2020

1 reference

Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling

31 March 2020

1 reference

The Bayesian population approach to physiological toxicokinetic-toxicodynamic models--an example using the MCSim software

31 March 2020

1 reference

Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model

31 March 2020

1 reference

Incorporating measures of variability and uncertainty into the prediction of in vivo hepatic clearance from in vitro data

31 March 2020

1 reference

Statins and the risk of idiopathic venous thromboembolism

31 March 2020

1 reference

More efficient clinical trials through use of scientific model-based statistical tests

31 March 2020

1 reference

Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model

31 March 2020

1 reference

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

31 March 2020

1 reference

Prediction of hepatic metabolic clearance: comparison and assessment of prediction models

31 March 2020

1 reference

Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors

31 March 2020

1 reference

Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocol.

31 March 2020

1 reference

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

31 March 2020

1 reference

Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences

31 March 2020

1 reference

Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices

31 March 2020

1 reference

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

31 March 2020

1 reference

Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance

31 March 2020

1 reference

Changes in liver volume from birth to adulthood: a meta-analysis.

31 March 2020

1 reference

Effect of food intake on cardiovascular control in patients with impaired autonomic function

31 March 2020

1 reference

Regulation of intestinal blood flow

31 March 2020

1 reference

The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change

31 March 2020

1 reference

In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values

31 March 2020

1 reference

Application of in silico approaches to predicting drug--drug interactions

31 March 2020

1 reference

Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles

31 March 2020

1 reference

Protein binding predictions in infants

31 March 2020

1 reference

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

31 March 2020

1 reference

Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling.

31 March 2020

1 reference

A review and assessment of potential sources of ethnic differences in drug responsiveness

31 March 2020

1 reference

Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat

31 March 2020

1 reference

A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy

31 March 2020

1 reference

No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins

31 March 2020

1 reference

Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2

31 March 2020

1 reference

The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example

31 March 2020

1 reference

Database analyses for the prediction of in vivo drug-drug interactions from in vitro data

31 March 2020

1 reference

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.

31 March 2020

1 reference

Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner.

31 March 2020

1 reference